DASATINIB
Showing all 11 results
DASAKAST 50 MG
Strength |
50 mg
|
Form |
Tablet
|
Manufacturer |
Aprazer
|
Composition |
Dasatinib Tablet 50 mg
|
Brand |
Dasakast
|
Packaging Size |
60 Tablets
|
Treatment |
Blood cancer (chronic myeloid leukaemia)
|
Packaging Type |
Bottle
|
DASAKAST 70 MG
Packaging Size |
60 Tablets
|
Brand |
Dasakast
|
Composition |
Dasatinib Tablet 70 mg
|
Manufacturer |
Aprazer
|
Treatment |
Blood cancer
|
Form |
Tablet
|
Packaging Type |
Bottle
|
DASAMYL 100 MG
Manufacturer |
MYLAN
|
Prescription/Non prescription |
Prescription
|
Composition |
DASATINIB TABLET
|
Brand |
DASAMYL
|
Packaging Size |
BOTTLE
|
DYRONIB 50 MG
Packaging Size |
60 Tablets in a bottle
|
Brand |
Dyronib
|
Composition |
Dasatinib 50mg
|
Manufacturer |
Hetero
|
Treatment |
chronic myeloid leukemia
|
Prescription/Non prescription |
Prescription
|
Form |
Tablet
|
DYRONIB 70 MG
Manufacturer |
Hetero Healthcare Limited
|
Packaging Size |
60 Tablets
|
Brand |
Dyronib
|
Composition |
Dasatinib (70mg)
|
Prescription/Non prescription |
Prescription
|
Form |
Tablet
|
Treatment |
Cancer
|
Country of Origin |
Made in India
|
INVESTA 100 MG
Packaging Size |
10 Tablets in a strip
|
Brand |
Invista 100mg
|
Composition |
Dasatinib 100mg
|
Manufacturer |
Dr.Reddy’s Laboratories Ltd
|
Treatment |
Blood cancer (Chronic myeloid leukaemia)
|
Prescription/Non prescription |
Prescription
|
Dose Strength |
100mg
|
Category |
Blood Cancer
|
Drug |
Dasatinib
|
Generic Name |
Dasatinib
|
INVESTA 50 MG
Strength |
50mg
|
Packaging Size |
10 tablets in a strip
|
Brand |
Invista 50mg
|
Composition |
Dasatinib 50mg
|
Manufacturer |
Dr.Reddy’s Laboratories Ltd
|
Dose Strength |
Blood cancer (Chronic myeloid leukaemia)
|
Category |
Blood Cancer
|
Drug |
Dasatinib
|
Generic Name |
Dasatinib
|
INVESTA 70 MG
Pack Size |
1*10 Tablet
|
Pack Type |
Strips
|
Manufacturer |
Dr Reddy’s Laboratories Ltd
|
Strength |
70 mg
|
Prescription/Non prescription |
Prescription
|
Composition |
Dasatinib
|
Brand |
Invista 70
|
Packaging Size |
30 Tablets
|
Treatment |
Blood Cancer
|
SPINIB 100 MG
Strength |
100 mg
|
Form |
Tablet
|
Pack Size |
1*30 Tablet
|
Usage/Application |
Personal
|
Pack Type |
Box
|
Compostion |
Dasatinib
|
Storage Condition |
As per label
|
Brand Name |
Spnib 100
|
Prescription/Non prescription |
Prescription
|
Manufacturer |
Zydus
|
Usages |
Blood cancer
|
Country of Origin |
Made in India
|
Spnib 100 |
Zydus
|
SPINIB 70 MG
Packaging Size |
60 Tablets
|
Brand |
Zydus
|
Composition |
Dasatinib
|
Treatment |
Blood cancer
|
Prescription/Non prescription |
Prescription
|
Form |
Tablet
|
Strength |
70 mg
|
Country of Origin |
Made in India
|
Online Sports Nutrition and Natural Dietetics.
Chances are there wasn't collaboration, communication, and checkpoints, there wasn't a process agreed upon or specified with the granularity required. It's content strategy gone awry right from the start. Forswearing the use of Lorem Ipsum wouldn't have helped, won't help now. It's like saying you're a bad designer, use less bold text, don't use italics in every other paragraph. True enough, but that's not all that it takes to get things back on track.
The villagers are out there with a vengeance to get that Frankenstein
You made all the required mock ups for commissioned layout, got all the approvals, built a tested code base or had them built, you decided on a content management system, got a license for it or adapted:
- The toppings you may chose for that TV dinner pizza slice when you forgot to shop for foods, the paint you may slap on your face to impress the new boss is your business.
- But what about your daily bread? Design comps, layouts, wireframes—will your clients accept that you go about things the facile way?
- Authorities in our business will tell in no uncertain terms that Lorem Ipsum is that huge, huge no no to forswear forever.
- Not so fast, I'd say, there are some redeeming factors in favor of greeking text, as its use is merely the symptom of a worse problem to take into consideration.
- Websites in professional use templating systems.
- Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template.
- When it's about controlling hundreds of articles, product pages for web shops, or user profiles in social networks, all of them potentially with different sizes, formats, rules for differing elements things can break, designs agreed upon can have unintended consequences and look much different than expected.
This is quite a problem to solve, but just doing without greeking text won't fix it. Using test items of real content and data in designs will help, but there's no guarantee that every oddity will be found and corrected. Do you want to be sure? Then a prototype or beta site with real content published from the real CMS is needed—but you’re not going that far until you go through an initial design cycle.